A defective retroviral vector encoding human interferon-α2 can transduce human leukemic cell lines

Cancer Gene Therapy

Volumn 5, Issue 4, 1998, Pages 247-256

  Austruy, Estelle ^a   Bagnis, Claude ^a   Carbuccia, Nadine ^b   Maroc, Christine ^a   Birg, Françoise ^b   Dubreuil, Patrice ^b   Mannoni, Patrice ^a   Chabannon, Christian ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b INSERM   (France)

Author keywords

Chronic myeloid leukemia; Gene therapy; Human interferon; Immunotherapy; Retroviral vector

Indexed keywords

ALPHA INTERFERON; ALPHA2 INTERFERON; BCR ABL PROTEIN; BETA GALACTOSIDASE; COMPLEMENT COMPONENT C3B RECEPTOR; HISTOCOMPATIBILITY ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON-ALPHA 2; POLYADENYLIC ACID;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; CHRONIC MYELOID LEUKEMIA; ERYTHROLEUKEMIA; GENETIC TRANSDUCTION; GENETICS; HUMAN; IMMUNOLOGY; LEUKEMIA; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MOUSE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; RETROVIRUS; VIROLOGY;

ANIMALS; BASE SEQUENCE; BETA-GALACTOSIDASE; BLOTTING, NORTHERN; CELL DIVISION; CLONING, MOLECULAR; FUSION PROTEINS, BCR-ABL; HISTOCOMPATIBILITY ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-ALPHA; LEUKEMIA; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MICE; MOLECULAR SEQUENCE DATA; POLY A; RECEPTORS, COMPLEMENT 3B; RETROVIRIDAE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032113347     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Jaiyesimi IA, Kantarjian HM, Estey EH. Advances in therapy for hairy cell leukemia. Cancer. 1993;72:5-16.
2. Mandelli F, Avvisati G, Amadori S, et al. Maintenance treatment with recombinant interferon alpha-2b in patients with multiple myeloma responding to conventional induction chemotherapy. N Engl J Med. 1990;322:1430-1434.
3. Solal-Celigny P, Lepage E, Brousse N, et al. Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma: groupe d'etude des lymphomes de l'adulte. N Engl J Med. 1993;329:1608-1614.
4. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Ann Intern Med. 1991;114:532-538.
5. Tura S, Baccarani M, Zuffa E, for the Italian cooperative study group on chronic myeloid leukemia. Interferon alfa-2a compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med. 1994;330:820-825.
6. Ozer H, George S, Schiffer C, et al. Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: cancer and leukemia group B study 8583. Blood. 1993;82:2975-2984.
7. Hehlman R, Heimpel H, Hashford J, et al. Randomized comparison of interferon-alfa with busulfan and hydroxyurea in chronic myelogenous leukemia. Blood. 1994;84: 4064-4077.
8. Fialkow PJ, Jacobson RT, Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, platelet and monocyte macrophage. Am J Med. 1977;63:125-130.
9. Nowell PC, Hungerford DA. A minute chromosome in human granulocytic leukemia. Science. 1960;132:1497.
10. Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature. 1985;315:550-554.
11. Daley GQ, van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210 BCR-ABL gene of the Philadelphia chromosome. Science. 1990; 247:824-830.
12. Gishizky ML, Johnson-White J, Witte ON. Efficient transplantation of BCR-ABL induced chronic myelogenous leukemia-like syndrome in mice. Proc Natl Acad Sci USA. 1993;90:3755-3759.
13. Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pettengale PK, Groffen J. Acute leukaemia in bcr/abl transgenic mice. Nature. 1990;344:251-253.
14. Appelbaum FR, Clift R, Radich J, Anasetti C, Buckner CD. Bone marrow transplantation for chronic myelogenous leukemia. Semin Oncol 1995;22:405-411.
15. Reiffers J, Trouette R, Marit G, et al. Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases. Br J Haematol. 1991;77:339-345.
16. Lee MS, Kantarjian H, Talpaz M, et al. Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy. Blood. 1992;79: 1920-1923.
17. Gronthos S, To LB, Haylock DN, Juttner CA. A differential sensitivity to recombinant human interferon alpha 2a between normal and chronic myeloid leukemic peripheral blood granulocyte-macrophage colony-forming units. Leuk Res. 1992;16:153-158.
18. Aman MJ, Keller U, Derigs G, Mohammadzadeh M, Huber C, Peschel C. Regulation of cytokine expression by interferon alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of IL-1 receptor antagonist. Blood. 1994;84: 4142-4150.
19. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF. Altered adhesive interactions with marrow stroma of haemopoietic progenitor cells in chronic myeloid leukemia. Nature. 1987;32:342-344.
20. Dowding C, Guo AP, Osterholz J, MS, Goldman J, Gordon J. Interferon-alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells. Blood. 1991;78:499-505.
21. Kühr T, Dougherty GJ, Klingemann HG. Transfer of the tumor necrosis factor alfa gene into hematopoietic progenitor cells as a model for site-specific cytokine delivery after marrow transplantation. Blood. 1994;84:2966-2970.
22. Mace K, Seif I, Anjard C, et al. Enhanced resistance to HIV-1 replication in U937 cells stably transfected with the human IFN-β gene behind a MHC promoter fragment. J Immunol. 1991;147:3553-3559.
23. Gansbacher B, Zier K, Cronin K, et al. Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells. Blood. 1992;80:2817-2825.
24. Kaido T, Bandu MT, Maury C, Ferrantini M, Belardelli F, Gresser I. IFN-αl gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice. Int J Cancer. 1995; 60:221-229.
25. Bednarik DP, Mosca JD, Raj NBK, Pitha PM. Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated α2-interferon. Proc Natl Acad Sci USA. 1989;86:4958-4962.
26. Su Y, Popik W, Pitha PM. Inhibition of human immunodeficiency virus type 1 replication by a tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells. J Virol. 1995; 69:110-121.
27. Cornetta K, Moore A, Leemhuis T, et al. Retroviral mediated gene transfer in chronic myelogenous leukaemia. Br J Haematol. 1994;87:308-316.
28. Bi C, Barton CM, Lemoine NR, Cross NCP, Goldman JM. Retroviral transduction of Philadelphia-positive chronic myeloid leukemia cells with a human mutant p53 cDNA and its effect on in vitro proliferation. Exp Hematol. 1994;22:95-99.
29. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood. 1994;83:3068-3076.
30. Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ. Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci USA. 1986;83: 5306-5310.
31. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vector occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol. 1990;10: 4239-4242.
32. Seigneurin D, Champelovier P, Mouchiroud G, et al. Human chronic myeloid leukemic cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics. Exp Hematol. 1987;15:822-32.
33. Kitamura T, Tange T, Terasawa T, et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol. 1989;140:323-334.
34. Viellard V, Lauret E, Rousseau V, De Maeyer E. Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon-β. Proc Natl Acad Sci USA. 1994;9:2689-2693.
35. Goeddel DV, Yelverton E, Ullrich A, et al. Human leukocyte interferon produced by E. coli is biologically active. Nature. 1980;287:411-416.
36. Maeda S, McCandliss R, Gross M, et al. Construction and identification of bacterial plasmids containing nucleotide sequences for human leukocyte interferon. Proc Natl Acad Sd USA. 1980;77:7010-7013.
37. Streuli M, Nagata S, Weissmann C. At least three human type alpha interferons: structure of alpha-2. Science. 1980; 209:1343-1347.
38. Goeddel DV, Leung DW, Dull TJ, et al. The structure of eight distinct cloned human leukocyte interferon cDNAs. Nature. 1981;290:20-26.
39. Lawn RM, Gross M, Houck CM, Francke AE, Gray PV, Goeddel DV. DNA sequence of a major human leukocyte interferon gene. Proc Natl Acad Sci USA. 1981;78:5435-5439.
40. Bowden DW, Mao J, Gill T, et al. Cloning of eukaryotic genes in single-strand phage vectors: the human interferon genes. Gene. 1984;27:87-99.
41. Diaz MO, Pomykala HM, Bohlander SK, et al. Structure of the human type-1 interferon gene cluster determined from a YAC clone contig. Genomics. 1994;22:540-552.
42. Gewert D, Salom C, Barber K, et al. Analysis of interferon-alpha 2 sequences in human genomic DNA. J Interferon Res. 1993;13:227-231.
43. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniqites. 1989;7:980-990.
44. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1989.
45. + cell populations and into TF-1 cells: future prospects in gene therapy. Hum Gene Ther. 1994;5:1325-1333.
46. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology. 1988;167:400-406.
47. Weiss R. Experimental biology and assay of RNA tumor viruses. In: Weiss R, Teich N, Varmus HE, Coffin J, eds. RNA Tumor Viruses. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1984:209-260.
48. Kariwa H, Arikawa J, Takashima I, Isegawa Y, Yamanishi K, Hashimoto N. Enhancement of infectivity of hantavirus in cell culture by centrifugation. J Virol Methods. 1994;49: 235-244.
49. Ho WZ, Cherukuri R, Ge SD, et al. Centrifugal enhancement of human immunodeficiency virus type 1 infection and human cytomegalovirus gene expression in human primary monocyte/macrophages in vitro. J Leukoc Biol. 1993;53:208-212.
50. Biguet NF, Buda M, Lamouroux A, Samolyk D, Mallet J. Time course of the changes of TH mRNA in rat brain and adrenal medulla after a single injection of reserpine. EMBO J. 1986;5:287-291.
51. Benech P, Mory Y, Revel M, Chebath J. Structure of two forms of the interferon-induced (2′-5′) oligo A synthetase of human cells based on cDNAs and gene sequence. EMBO J. 1985:4:2249-2256.
52. Artelt P, Grannemann R, Stocking C, Friel J, Bartsch J, Hauser H. The prokaryotic neomycin-resistance gene acts as a transcriptional silencer in eukaryotic cells. Gene. 1991;99:249-254.
53. Ekhterae D, Crumbleholme T, Karson E, Harrison MR, Anderson WF, Zanjani ED. Retroviral vector-mediated transfer of the bacterial neomycin resistance gene into fetal and adult sheep and human hematopoietic progenitors in vitro. Blood. 1990;75:365-369.
54. Smetsers TF, van de Locht LT, Pennings AH, Wessels HM, de Witte TM, Mensink EJ. Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death but fail to reduce cellular bcr-abl protein levels. Leukemia. 1995; 9:118-130.
55. Burke F, Stuart-Naylor M, Davies B, Balkwill F. The cytokine wall chart. Immunol Today. 1993;14:165-169.
56. Diaz MO, Ziemin S, Le Beau MM, et al. Homozygous deletion of the alfa- and β1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci USA. 1988:85:5259-5263.
57. Tkachuk DC, Wrestbrook CA, Andreeff M, et al. Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science. 1990;250:550-62.